Amanote Research

Amanote Research

  • Register
  • Sign In

Genetic and Pharmacological Regulation of the Endocannabinoid CB1 Receptor in Duchenne Muscular Dystrophy

Nature Communications- United Kingdom

doi 10.1038/s41467-018-06267-1

Full Text

Abstract

Available in

Categories

AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics

Date

September 27, 2018

Authors

Fabio A. IannottiEster PaganoOmbretta GuardiolaSimone AdinolfiValentina SacconeSilvia ConsalviFabiana PiscitelliElisabetta GazzerroGiuseppe BusettoDiego CarrellaRaffaele CapassoPier Lorenzo PuriGabriella MinchiottiVincenzo Di Marzo

Publisher

Springer Science and Business Media LLC


Related search

Duchenne Muscular Dystrophy

Methods in Molecular Biology
GeneticsMolecular Biology
2018English

Duchenne Muscular Dystrophy

2020English

Duchenne Muscular Dystrophy

Physiotherapy
Physical TherapySports TherapyRehabilitation
1990English

Duchenne Muscular Dystrophy

English

Therapy of Genetic Disorders: Novel Therapies for Duchenne Muscular Dystrophy

Current Pediatrics Reports
2014English

Duchenne Muscular Dystrophy and Brain Function

2012English

Disability and Survival in Duchenne Muscular Dystrophy

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
2009English

Airway Clearance in Duchenne Muscular Dystrophy

Pediatrics
Child HealthPediatricsPerinatology
2009French

Bladder Dysfunction in Duchenne Muscular Dystrophy

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
2003German

Amanote Research

Note-taking for researchers

Follow Amanote


© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy